about
Stem cells as drug delivery methods: application of stem cell secretome for regenerationCellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy?Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout miceUrinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus.DNMT1 and HDAC2 Cooperate to Facilitate Aberrant Promoter Methylation in Inorganic Phosphate-Induced Endothelial-Mesenchymal Transition.Elevated plasma levels of endostatin are associated with chronic kidney disease.Precision renal medicine: a roadmap towards targeted kidney fibrosis therapies.Ferulic Acid, an Angelica sinensis-Derived Polyphenol, Slows the Progression of Membranous Nephropathy in a Mouse ModelEndostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.Diabetic angiopathy and angiogenic defects.Proteomic profiling and pathway analysis of the response of rat renal proximal convoluted tubules to metabolic acidosis.Remnant nephron physiology and the progression of chronic kidney disease.Renal vascular structure and rarefaction.Cross talk between primary human renal tubular cells and endothelial cells in cocultures.The effect of Chinese medicine Pu-Ren-Dan on pancreatic angiogenesis in high fat diet/streptozotocin-induced diabetic rats.Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis.Angiostatin production increases in response to decreased nitric oxide in aging rat kidney.Renal inflammatory changes in acute hepatic failure-associated acute kidney injury.Modeling angiogenesis with micro- and nanotechnology.Restoring the renal microvasculature to treat chronic kidney disease.The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
P2860
Q26862657-36F58D77-BDBC-4D05-9A42-EB0CCF0EE5F7Q30443462-6D20FE2A-FB50-474B-BBEB-447FD7DD3837Q33764597-2FF3C68B-A39E-49B3-BA4D-5E4CE6FA8CCAQ34257934-3AD120A8-5A31-427A-A080-D602369041BFQ34412951-2F5BE468-CDC7-4EA7-83B0-1040E3B6528BQ35250569-EFBFAAF4-EC87-4A4F-86FD-3C3DD80298EAQ35905516-54BFB000-E083-4566-96C2-F966C4300D21Q35994570-D6C36F4B-B450-4400-BAA3-04DB5BC67011Q36015077-FD5A8BBD-BF45-41A2-9F16-ED880CBC0BC4Q36111720-945F6A4C-FCFE-4E62-8820-CADEC0A22A59Q36220259-1E98BB65-1225-4343-B904-4DABF41A46F4Q36301365-6D7CD02D-D9BE-49E7-A4A6-8DBE6919903DQ37142492-8B065680-507B-4886-B71A-2063077662F8Q37228467-EFC74814-65D5-4C55-ABA5-0263A7B125E0Q37605855-EF84236F-A5ED-4A34-BCA0-F227E2ADC4DDQ39399388-EB4611BD-929D-48D2-86E9-65CFE859E630Q42104863-A1E883F0-727C-4E0B-A2C3-430861B0434FQ42715235-8807FD5F-EC02-4DC9-B424-C2A154598E8CQ43641614-E2107B65-23D9-48B9-815D-C10362B57829Q44202870-68B695C8-7540-4381-9BC3-460840224842Q47598622-5853B77A-7258-427C-9DAD-6A2CE173BD47Q51632066-ABDAF437-40A5-41ED-9E62-6F48F4D25E16Q54573751-EECBA3C8-555B-46BC-8FBF-720082B47CE4
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angiogenesis and chronic kidney disease.
@ast
Angiogenesis and chronic kidney disease.
@en
Angiogenesis and chronic kidney disease.
@nl
type
label
Angiogenesis and chronic kidney disease.
@ast
Angiogenesis and chronic kidney disease.
@en
Angiogenesis and chronic kidney disease.
@nl
prefLabel
Angiogenesis and chronic kidney disease.
@ast
Angiogenesis and chronic kidney disease.
@en
Angiogenesis and chronic kidney disease.
@nl
P2860
P356
P1476
Angiogenesis and chronic kidney disease.
@en
P2093
Hirofumi Makino
Yohei Maeshima
P2860
P2888
P356
10.1186/1755-1536-3-13
P577
2010-08-05T00:00:00Z
P5875
P6179
1006912184